胺碘酮诱发的甲状腺毒症:使用99mTc-甲氧基异丁基异腈及靶本底比值进行鉴别诊断
该回顾性研究纳入30例胺碘酮诱发的甲状腺毒症患者,评估99mTc-甲氧基异丁基异腈甲状腺显像定性及靶本底比值定量对AIT-1与AIT-2的鉴别价值。以临床治疗反应为金标准,ROC曲线分析显示靶本底比值0.482为最佳截断值,鉴别AIT-1与AIT-2的灵敏度为91.7%、特异度为100%(P<0.0001,曲线下面积0.982)。作者认为该方法有助于区分两型并指导治疗。
要点
- 99mTc-甲氧基异丁基异腈甲状腺显像的靶本底比值0.482可区分AIT-1与AIT-2,灵敏度91.7%、特异度100%。
- 定性评估中1/14例AIT-1和6/12例AIT-2被误诊为混合型。
- 作者认为该方法可避免无意义且潜在危险的联合过度治疗,并可能加速甲状腺功能恢复。
核心结论
- 作者认为,结合靶本底比值,99mTc-甲氧基异丁基异腈甲状腺显像在区分AIT-1与AIT-2方面非常有用,从而可根据诊断给予患者适当治疗。
研究设计与样本
- 回顾性评估30例胺碘酮诱发的甲状腺毒症患者(11例女性、19例男性)的99mTc-甲氧基异丁基异腈甲状腺显像,在平面图像上获取靶本底比值,并与定性评估及最终临床诊断进行相关性分析。
主要发现
- 以临床治疗反应为金标准,鉴定出14例AIT-1、12例AIT-2和4例混合型。
- 定性评估识别出全部混合型,但1/14例AIT-1和6/12例AIT-2被误诊为混合型。
- ROC曲线分析显示,靶本底比值0.482为区分AIT-1与AIT-2的截断值,特异度100%、灵敏度91.7%(P<0.0001,曲线下面积0.982)。
关键数值与推荐
- 靶本底比值0.482作为99mTc-甲氧基异丁基异腈甲状腺显像中区分AIT-1与AIT-2的截断值,特异度100%、灵敏度91.7%(P<0.0001,曲线下面积0.982)。
临床怎么用
- 作者认为,结合靶本底比值,99mTc-甲氧基异丁基异腈甲状腺显像有助于区分AIT-1与AIT-2,从而根据诊断给予患者适当治疗。
- 作者认为,该方法可避免无意义且潜在危险的联合过度治疗,并可能加速甲状腺功能恢复正常,这对患有心脏病的AIT患者至关重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE OF THE REPORT: Distinguishing between amiodarone-induced thyrotoxicosis (AIT) caused by excessive hormone synthesis (AIT-1) or by a destructive process (AIT-2) has important therapeutic implications, but is still difficult and debated. Tc-sestaMIBI thyroid scintigraphy (99m-STS) has been proposed as a tool for classifying the two forms. MATERIAL AND METHODS: 30 AIT patients (11 females and 19 males) who underwent 99m-STS were retrospectively assessed for the present study. For each patient, a target-to-background ratio (TBR) was obtained on planar images. The TBR was then correlated with the qualitative assessment of the scans and the final clinical diagnosis. RESULTS: Considering clinical response to treatment as the gold standard for differential diagnosis, 14 cases of AIT-1, 12 of AIT-2, and 4 mixed forms were identified. 99m-STS was able to qualitatively identify all the mixed forms, while 1/14 AIT-1 and 6/12 AIT-2 cases were misdiagnosed as mixed forms. When the quantitative index (the TBR) was compared with the final clinical diagnosis, ROC curve analysis enabled us to identify an IBR of 0.482 during 99m-STS as a cut-off capable of discriminating between AIT-1 and AIT-2, with 100% specificity and 91.7% sensitivity (P < 0.0001, area under the curve: 0.982). CONCLUSIONS: Taking the TBR into consideration, 99m-STS proved a very useful tool for distinguishing AIT-1 from AIT-2, and thus offering patients appropriate treatment as of their diagnosis. This approach can avoid pointless and potentially dangerous combined overtreatments, and may speed up the return to normal thyroid function, which is crucial in AIT patients suffering from heart disease.
引用
- Censi S, Bodanza V, Manso J, et al. Amiodarone-Induced Thyrotoxicosis: Differential Diagnosis Using 99mTc-SestaMIBI and Target-to-Background Ratio (TBR). Clin Nucl Med. 2018. PMID: 30036255. doi:10.1097/RLU.0000000000002207
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。